Revenue, last quarter
$1.3M
+60.6% vs same quarter last year
Net income
$491K
+223% vs same quarter last year
EPS, diluted
$0.04
+300% vs same quarter last year
Operating cash flow
$1.3M
+26.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $3M | −$569K |
| FY24 | $1.8M | −$2.2M |
| FY23 | $1.3M | −$10.3M |
| FY22 | $70M | $112M |
| FY21 | $2.6M | −$172.4M |
| FY20 | $64.9M | −$183.5M |
| FY19 | $49.6M | −$176.1M |
| FY18 | $16.1M | −$132.6M |
| FY17 | $16.8M | −$76.9M |
| FY16 | $19.4M | −$89.9M |
| FY15 | $20.1M | −$85.1M |
| FY14 | $15M | −$54.2M |
| FY13 | $8.8M | −$28.4M |
| FY12 | $3.8M | −$35.1M |
| FY11 | $2.1M | −$12.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −145.3% | −18.8% |
| FY24 | - | −347.1% | −123.9% |
| FY23 | 100% | −654.6% | −789.4% |
| FY22 | 98% | 1.7% | 160.1% |
| FY21 | 45.5% | −3092.8% | −6700.9% |
| FY20 | 75.4% | −239.8% | −282.9% |
| FY19 | 87.2% | −304.6% | −354.8% |
| FY18 | 83% | −808.8% | −823.7% |
| FY17 | 84.3% | −462.7% | −458.5% |
| FY16 | 78.4% | −466.3% | −464.3% |
| FY15 | 77.6% | −422.9% | −422.4% |
| FY14 | 75.6% | −359.6% | −360.8% |
| FY13 | 77.7% | −294.1% | −323.8% |
| FY12 | 64.7% | −423% | −919.9% |
| FY11 | 54.6% | −259.9% | −618.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | −$142.7M |
| FY20 | −$159.7M |
| FY19 | −$168.2M |
| FY18 | −$107M |
| FY17 | −$76.2M |
| FY16 | −$69.5M |
| FY15 | −$79.2M |
| FY14 | −$45.6M |
| FY13 | −$20.8M |
| FY12 | −$12.8M |
| FY11 | −$5M |
- TherapeuticsMD
- Healthcare median
Show the numbers
| Year | TherapeuticsMD | Healthcare median |
|---|---|---|
| FY25 | −18.8% | −30.6% |
| FY24 | −123.9% | −47% |
| FY23 | −789.4% | −58% |
| FY22 | 160.1% | −80.4% |
| FY21 | −6700.9% | −71.8% |
| FY20 | −282.9% | −62.2% |
| FY19 | −354.8% | −46.2% |
| FY18 | −823.7% | −49.6% |
| FY17 | −458.5% | −45.9% |
| FY16 | −464.3% | −36% |
| FY15 | −422.4% | −37.8% |
| FY14 | −360.8% | −35.5% |
| FY13 | −323.8% | −37.1% |
| FY12 | −919.9% | −29.1% |
| FY11 | −618.4% | −27.9% |